ConductScience.org, home

Trial · NCT03852992

Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia

NCT03852992, Phase 2, Withdrawn, University of Minnesota

3 sourcestrials-2026-11-12-0.4.0

Download JSON
Cite this record

ConductScience Library. Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia. Trials, record NCT03852992. Release trials-2026-11-12-0.4.0, 12 Nov 2026. https://conductscience.org/library/trials/NCT03852992

On this page

Trial

As registered on ClinicalTrials.gov, in the graph's capture of the registry.

Title
Laser Assisted Delivery of Minoxidil in Androgenetic Alopecia
NCT number
NCT03852992
Status
Withdrawn
Phases
Phase 2
Enrollment
0 participants, actual
Lead sponsor
University of Minnesota
Conditions
Male Pattern Hair Loss, Androgenetic Alopecia, Male Pattern Baldness
Interventions
Post-Laser Minoxidil 2%, At-Home Minoxidil 5%, Laser, Post-laser 5mg minoxidil, Post-laser 10mg minoxidil, Post-laser 20mg minoxidil
First posted
2019-02-25
Last updated
2023-09-13

Source ClinicalTrials.gov

Registered outcomes6

Each outcome the trial registered, primary first, in ClinicalTrials.gov's words.

ListOutcomeTime frameDescription
PrimaryHair Growth Assessment (HGA)End of trial (8-16 weeks)Scale indicating graded degree of change represented as no change, worse outcome, better outcome.
PrimaryHair Growth Index (HGI)End of trial (8-16 weeks)Hair growth is compared from baseline by three self-report questions on a health outcome questionnaire
PrimaryChange in Hair Growth Satisfaction Scale (HGSS)Week 0, Week 4(+4), Week 8(+4)Hair appearance/growth is compared from baseline by five self-report questions that rank satisfaction with hair growth on a scale from -3 (very dissatisfied) to 3 (very satisfied).
PrimaryChange in Investigator Global Assessment of PhotographyWeek 0, end of trial (8-16 weeks)Scale from -3 (significant worsening) to 3 (significant improvement) assessing hair loss/growth
SecondaryChange in Additional Investigator Global Assessment of PhotographyWeek 0, end of trial (8-16 weeks)Scale from -3 (significant worsening) to 3 (significant improvement) assessing hair loss/growth
SecondaryChange in Scalp Symptom AssessmentsWeek 0, Week 4(+4), Week 8(+4)Measure 4 criteria, erythema, scaling, pruritis, and burning/stinging, on a scale from 0 (none) to 4 (severe)

Outcomes0

Each outcome the trial posted results for, in ClinicalTrials.gov's words.

None in this release.

Results by group0

Each measurement the trial posted, group by group, in the words and numbers it posted.

None in this release.

Participant flow0

How many started, completed or left each group, period by period.

None in this release.

Adverse events0

Each adverse event the trial posted, group by group: the participants affected out of those at risk.

None in this release.

Adverse event totals0

The totals the trial posted for each group.

None in this release.

Papers0

The papers the trial lists on ClinicalTrials.gov.

None in this release.

Grants0

The grants NIH RePORTER links to the trial, newest funded first: NIH's, and some of AHRQ's, CDC's, FDA's and VA's. Each shows its title, principal investigators, organization and funder in its newest year.

None in this release.

Trial comparisons0

Comparisons of the trial's two groups, calculated by ConductScience from the counts it posted.

None in this release.

Tests0

The ConductCognition tests this trial's registered outcomes name, as ScienceGraph matched them in trial-tests-2026-11-12-0.2.1.

None in this release.

Data dates

The day each source was copied for this release.

ClinicalTrials.gov
2026-11-12
ClinicalTrials.gov
Results, from AACT
2026-03-23
AACT
NIH grant links
2026-11-13
NIH RePORTER

Sources 3

  • ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
  • ClinicalTrials.govNo license stated
  • NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
  • ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
  • ClinicalTrials.govnone stated
  • NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)

ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.

For software

Read this trial from software.

The record and each of its lists are JSON, twenty rows a page. No key.

GET https://conductscience.org/api/trials/v1/NCT03852992

GET https://conductscience.org/api/trials/v1/NCT03852992/registered